MedicalCodify.com
Search Term or Code: Advanced Search 
Geek Mode


Measure: CMS153

Chlamydia Screening for Women

Measure Versions

eMeasure Code Measure Year Full Version Number Title
CMS153v12 2024 12.0.000 Chlamydia Screening in Women
CMS153v11 2023 11 Chlamydia Screening for Women
CMS153v10 2022 10.0.000 Chlamydia Screening for Women
CMS153v9 2021 9.2.000 Chlamydia Screening for Women
CMS153v8 2020 8.1.000 Chlamydia Screening for Women
CMS153v7 2019 7.4.000 Chlamydia Screening for Women
CMS153v6 2018 6.2.000 Chlamydia Screening for Women
CMS153v5 2017 5.0.000 Chlamydia Screening for Women

Description

Percentage of women 16-24 years of age who were identified as sexually active and who had at least one test for chlamydia during the measurement period.

Guidance

Patient Group Definitions

Group Description Instructions Links
Initial PopulationWomen 16 to 24 years of age by the end of the measurement period who are sexually active and who had a visit in the measurement periodWebchart Instructions
DenominatorEquals Initial PopulationWebchart Instructions
Denominator ExclusionsWomen who are only eligible for the initial population due to a pregnancy test and who had an order for an x-ray or for a specified medication within 7 days of the pregnancy test. Exclude patients who are in hospice care for any part of the measurement period.Webchart Instructions
NumeratorWomen with at least one chlamydia test during the measurement periodWebchart Instructions
Numerator ExclusionsNot ApplicableWebchart Instructions
Denominator ExceptionsNone

Details

Full eMeasure Code eMeasure Identifier Measure Year Version NQF # GUID
CMS153v11 153 2023 11 N/A c9930664-be3d-4ffe-ae4a-5cf4933ecb89
Steward Developer Endorsed By
National Committee for Quality Assurance National Committee for Quality Assurance None
Scoring Method Measure Type Stratification Risk Adjustment
Proportion Process Report a total score, and each of the following strata: Stratum 1: Patients age 16-20 by the end of the measurement period Stratum 2: Patients age 21-24 by the end of the measurement period None

Rate Aggregation

None

Improvement Notation

Higher score indicates better quality

Rationale

Clinical Recommendation Statement


Definition

Transmission Format

Applicable Value Sets

Category Value Set OID
Diagnosis Complications of Pregnancy, Childbirth and the Puerperium 2.16.840.1.113883.3.464.1003.111.12.1012
Diagnosis Diagnoses Used to Indicate Sexual Activity 2.16.840.1.113883.3.464.1003.111.12.1018
Diagnosis HIV 2.16.840.1.113883.3.464.1003.120.12.1003
Diagnostic Study, Order Diagnostic Studies During Pregnancy 2.16.840.1.113883.3.464.1003.111.12.1008
Diagnostic Study, Order X-Ray Study (all inclusive) 2.16.840.1.113883.3.464.1003.198.12.1034
Encounter, Performed Encounter Inpatient 2.16.840.1.113883.3.666.5.307
Encounter, Performed Home Healthcare Services 2.16.840.1.113883.3.464.1003.101.12.1016
Encounter, Performed Hospice Encounter 2.16.840.1.113883.3.464.1003.1003
Encounter, Performed Office Visit 2.16.840.1.113883.3.464.1003.101.12.1001
Encounter, Performed Online Assessments 2.16.840.1.113883.3.464.1003.101.12.1089
Encounter, Performed Preventive Care - Established Office Visit, 0 to 17 2.16.840.1.113883.3.464.1003.101.12.1024
Encounter, Performed Preventive Care Services - Established Office Visit, 18 and Up 2.16.840.1.113883.3.464.1003.101.12.1025
Encounter, Performed Preventive Care Services-Initial Office Visit, 18 and Up 2.16.840.1.113883.3.464.1003.101.12.1023
Encounter, Performed Preventive Care- Initial Office Visit, 0 to 17 2.16.840.1.113883.3.464.1003.101.12.1022
Encounter, Performed Telephone Visits 2.16.840.1.113883.3.464.1003.101.12.1080
Intervention, Order Hospice Care Ambulatory 2.16.840.1.113883.3.526.3.1584
Intervention, Performed Hospice Care Ambulatory 2.16.840.1.113883.3.526.3.1584
Laboratory Test, Order Lab Tests During Pregnancy 2.16.840.1.113883.3.464.1003.111.12.1007
Laboratory Test, Order Lab Tests for Sexually Transmitted Infections 2.16.840.1.113883.3.464.1003.110.12.1051
Laboratory Test, Order Pap Test 2.16.840.1.113883.3.464.1003.108.12.1017
Laboratory Test, Order Pregnancy Test 2.16.840.1.113883.3.464.1003.111.12.1011
Laboratory Test, Performed Chlamydia Screening 2.16.840.1.113883.3.464.1003.110.12.1052
Medication, Active Contraceptive Medications 2.16.840.1.113883.3.464.1003.196.12.1080
Medication, Order Contraceptive Medications 2.16.840.1.113883.3.464.1003.196.12.1080
Medication, Order Isotretinoin 2.16.840.1.113883.3.464.1003.196.12.1143
Patient Characteristic Ethnicity Ethnicity 2.16.840.1.114222.4.11.837
Patient Characteristic Payer Payer 2.16.840.1.114222.4.11.3591
Patient Characteristic Race Race 2.16.840.1.114222.4.11.836
Patient Characteristic Sex ONC Administrative Sex 2.16.840.1.113762.1.4.1
Procedure, Performed Procedures Used to Indicate Sexual Activity 2.16.840.1.113883.3.464.1003.111.12.1017

References


Disclaimer

Copyright


Source: https://ecqi.healthit.gov/ecqm/measures/cms153v1